Indeed, it has been reported that low doses of TRAIL promote tumor cell invasion and metastasis by activating p-STAT3 in non-small cell lung cancer [4, 40] and that TRAIL induces a significant amount of apoptosis in a human T-cell line in a dose-dependent manner [41]. Here, TNFSF10 is linked to non-small cell lung carcinoma.